XML 86 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
 12 Months Ended
Nov. 15, 2023
Sep. 05, 2023
Jul. 10, 2023
Feb. 28, 2022
Dec. 10, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2018
Dec. 31, 2016
Loss Contingencies [Line Items]                  
Proceeds from issuance of common stock           $ 10,000,000    
Purchase obligation           $ 63,000      
Stock issued during period shares new issues 79,330   100,000       400,000    
Number of additional shares issued     100,000            
Shares issued, price per share     $ 5.32     $ 5.32      
Income tax deficiency   $ 1,900,000              
Harborside Advisors LLC [Member]                  
Loss Contingencies [Line Items]                  
Stock issued during period, shares, reverse stock splits         1,000,000        
Stock issued during period, shares, stock splits         200,000        
Stockholders' equity, reverse stock split         5-for-1 reverse stock split        
Revenue         $ 10,000,000        
Shares issued         1,000,000        
Incurred damages         $ 75,000        
Harborside Advisors LLC [Member] | Maximum [Member]                  
Loss Contingencies [Line Items]                  
Loss contingency, damages sought, value         33,000,000.0        
Harborside Advisors LLC [Member] | Minimum [Member]                  
Loss Contingencies [Line Items]                  
Loss contingency, damages sought, value         $ 5,000,000.0        
Conversion Labs Rx Business [Member]                  
Loss Contingencies [Line Items]                  
Stock issued during period, shares, stock splits         200,000        
Conversion Labs Rx Business [Member] | Maximum [Member]                  
Loss Contingencies [Line Items]                  
Stock issued during period, shares, stock splits         1,000,000        
Pilaris Laboratories, LLC [Member]                  
Loss Contingencies [Line Items]                  
Finite-lived intangible asset, useful life                 10 years
Intercompany agreements, description                 As consideration for granting Conversion Labs PR this license, Pilaris will receive on quarterly basis, 10% of the net income collected by the licensed products based on the following formula: Net Income = total income – cost of goods sold – advertising and operating expenses directly related to the marketing of the licensed products.
Percentage of net income                 10.00%
Accrued expenses           $ 5,000 $ 138,000    
Payment for agreement           $ 138,000 $ 0    
M.ALPHABET, LLC [Member]                  
Loss Contingencies [Line Items]                  
Intercompany agreements, description               The Company shall pay Alphabet a royalty equal to 13% of Gross Receipts (as defined in the Agreement) realized from the sales of Licensed Products. No amounts were earned or owed as of December 31, 2023.  
Share based compensation arrangement by share based payment award, expiration period               10 years  
Stock option to purchase shares               20,000  
Stock option exercise price               $ 2.50  
M.ALPHABET, LLC [Member] | Common Stock One [Member]                  
Loss Contingencies [Line Items]                  
Stock option to purchase shares               20,000  
Stock option exercise price               $ 2.50  
Proceeds from issuance of common stock               $ 7,500,000  
M.ALPHABET, LLC [Member] | Common Stock Two [Member]                  
Loss Contingencies [Line Items]                  
Stock option to purchase shares               20,000  
Stock option exercise price               $ 2.50  
Proceeds from issuance of common stock               $ 10,000,000.0  
M.ALPHABET, LLC [Member] | Common Stock Three [Member]                  
Loss Contingencies [Line Items]                  
Stock option to purchase shares               40,000  
Stock option exercise price               $ 3.75  
Proceeds from issuance of common stock               $ 20,000,000.0  
Conversion Labs Rx Business [Member]                  
Loss Contingencies [Line Items]                  
Contigency contract amount         $ 274,000        
Conversion Labs Rx Business [Member] | Harborside Advisors LLC [Member]                  
Loss Contingencies [Line Items]                  
Stock issued in issuance costs         5,000,000        
Conversion Labs Rx Business [Member] | Harborside Advisors LLC [Member] | Maximum [Member]                  
Loss Contingencies [Line Items]                  
Stock issued in issuance costs         $ 5,000,000        
Blair LLC [Member]                  
Loss Contingencies [Line Items]                  
Contigency contract amount       $ 1,000,000.0